Štádler Petr, Dvořáček Libor, Vitásek Petr, Matouš Pavel
Department of Vascular Surgery, Na Homolce Hospital, Prague 5 15030, Czech Republic.
Innovations (Phila). 2012 Jul-Aug;7(4):247-53. doi: 10.1097/IMI.0b013e31827333cb.
The feasibility of robotically assisted laparoscopic aortic surgery has already been adequately demonstrated. Our clinical experience with robot-assisted aortoiliac reconstruction for occlusive diseases, aneurysms, and hybrid procedures performed using the Da Vinci system is described below.
Between November 2005 and November 2011, we performed 225 robot-assisted laparoscopic aortoiliac procedures. One hundred seventy-four patients were prospectively evaluated for occlusive diseases, 43 patients for abdominal aortic aneurysm, two for common iliac artery aneurysm, two for splenic artery aneurysm, three for hybrid procedures, and one for endoleak II treatment after endovascular aneurysm repair. The robotic system was applied to construct the vascular anastomosis for thromboendarterectomy, for aortoiliac reconstruction with a closure patch, for dissection of the splenic artery, and for posterior peritoneal suturing. A combination of conventional laparoscopic surgeries and robotic surgeries was routinely included. A modified fully robotic approach without laparoscopic surgery was used in the last 55 cases in our series.
Two hundred seventeen cases (96%) were successfully completed robotically; one patient's surgery was discontinued during laparoscopy because of heavy aortic calcification. In seven patients (3%), conversion was necessary. The 30-day mortality rate was 0.4%, and nonlethal postoperative complications were observed in 10 patients (4.4%).
Our experience with robot-assisted laparoscopic surgery has demonstrated the feasibility of this technique for aortoiliac vascular and hybrid procedures. Compared with purely laparoscopic techniques, the Da Vinci robotic system facilitated the creation of the aortic anastomosis and shortened the aortic clamping time.
机器人辅助腹腔镜主动脉手术的可行性已得到充分证明。以下介绍我们使用达芬奇系统进行机器人辅助的主髂动脉重建术治疗闭塞性疾病、动脉瘤及杂交手术的临床经验。
2005年11月至2011年11月期间,我们进行了225例机器人辅助腹腔镜主髂动脉手术。对174例患有闭塞性疾病的患者、43例腹主动脉瘤患者、2例髂总动脉瘤患者、2例脾动脉瘤患者、3例杂交手术患者以及1例血管腔内动脉瘤修复术后内漏II型治疗患者进行了前瞻性评估。机器人系统用于构建血管吻合,以进行血栓内膜切除术、带闭合补片的主髂动脉重建、脾动脉解剖以及后腹膜缝合。常规包括传统腹腔镜手术和机器人手术的联合应用。在我们系列的最后55例病例中采用了改良的完全机器人手术方法,不进行腹腔镜手术。
217例(96%)手术通过机器人成功完成;1例患者因主动脉重度钙化在腹腔镜手术期间手术中断。7例患者(3%)需要中转。30天死亡率为0.4%,10例患者(4.4%)出现非致命性术后并发症。
我们机器人辅助腹腔镜手术的经验证明了该技术用于主髂动脉血管及杂交手术的可行性。与单纯腹腔镜技术相比,达芬奇机器人系统有助于创建主动脉吻合并缩短主动脉阻断时间。